Related Experiment Video

Updated: May 14, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function

Reza Rahbari1, Mio Kitano, Lisa Zhang

  • 1Endocrine Oncology Branch, Clinical Research Center, 10 Center Drive, MSC 1201, National Cancer Institute, Bethesda, Maryland 20892, USA.

The Journal of Clinical Endocrinology and Metabolism
|February 9, 2013
PubMed
Abstract

Insights

Reticulon 4 interacting protein 1 (RTN4IP1) is down-regulated in thyroid cancer, suggesting a tumor-suppressive role. Its reduced expression correlates with larger tumors and increased cancer cell proliferation and invasion.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Reticulon 4 interacting protein 1 (RTN4IP1) is differentially expressed in thyroid cancer.
  • The RTN4IP1 gene is located on chromosome 6q21, a region often altered in malignancies.

Purpose of the Study:

  • To characterize RTN4IP1 expression in normal, hyperplastic, and cancerous thyroid tissues.
  • To evaluate the functional role of RTN4IP1 in thyroid cancer cell phenotypes.

Main Methods:

  • RTN4IP1 mRNA expression analysis in various thyroid tissue types.
  • Small interfering RNA (siRNA) knockdown of RTN4IP1 in three thyroid cancer cell lines (papillary, follicular, Hürthle cell).
  • Assessment of malignant cell phenotypes: proliferation, migration, invasion, apoptosis, spheroid formation, and anchorage-independent growth.

Main Results:

  • RTN4IP1 mRNA expression was significantly lower in follicular and papillary thyroid cancers compared to normal, hyperplastic, and benign tissues.
  • Lower RTN4IP1 expression correlated with larger papillary thyroid cancers.
  • RTN4IP1 knockdown increased proliferation, invasion, migration, colony formation, and tumor spheroid formation in cancer cell lines.

Conclusions:

  • RTN4IP1 is down-regulated in thyroid cancer and linked to larger tumor size.
  • RTN4IP1 plays a role in regulating malignant cell phenotypes.
  • RTN4IP1 exhibits tumor-suppressive functions and may influence thyroid cancer progression.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...